MEIP · Categories · Form 4

MEIP - SEC Form 4 insider transactions

MEI Pharma Inc. (MEIP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MEIP

• 291d
  SEC Form 4 filed by Director Riezman Joshua

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 325d
  SEC Form 4 filed by Director Wood Steven D

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 325d
  SEC Form 4 filed by Director Reynolds Thomas C

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 325d
  SEC Form 4 filed by Director Glover Nicholas

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 325d
  SEC Form 4 filed by Director Flynn James P

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 325d
  SEC Form 4 filed by Secretary, Acting CEO & CFO File Justin J.

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 325d
  SEC Form 4 filed by Director Driscoll Frederick W

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 748d
  Wood Steven D was granted 3,100 shares, increasing direct ownership by 246% to 4,359 units (SEC Form 4)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 749d
  Flynn James P was granted 7,900 shares (SEC Form 4)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 878d
  SEC Form 4 filed by Flynn James P (Amendment)

  4/A - MEI Pharma, Inc. (0001262104) (Issuer)
• 878d
  SEC Form 4 filed by Wood Steven D (Amendment)

  4/A - MEI Pharma, Inc. (0001262104) (Issuer)
• 900d
  SEC Form 4 filed by Wood Steven D

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 900d
  SEC Form 4 filed by Flynn James P

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 957d
  Funicular Funds, Lp exercised 120,600 in-the-money shares at a strike of $7.00 (SEC Form 4)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 957d
  Anson Funds Management Lp exercised 179,000 in-the-money shares at a strike of $7.00 (SEC Form 4)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 968d
  Funicular Funds, Lp exercised 30,000 in-the-money shares at a strike of $7.00 (SEC Form 4)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  Anson Funds Management Lp exercised 50,000 in-the-money shares at a strike of $7.00 (SEC Form 4)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Baltic Charles V. Iii

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Driscoll Frederick W

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Glover Nicholas

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Gold Daniel P Phd

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Howson Tamar D

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Reynolds Thomas C

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Kango Sujay

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 969d
  SEC Form 4 filed by Ghalie Richard G

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1098d
  SEC Form 4 filed by Urso David M

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1194d
  SEC Form 4: Baltic Charles V. Iii bought $18,338 worth of shares (81,500 units at $0.23), increasing direct ownership by 336% to 105,750 units

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1431d
  SEC Form 4 filed by Baltic Charles V. Iii

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Driscoll Frederick W

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Glover Nicholas

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Howson Tamar D

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Gold Daniel P Phd

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Cohen Cheryl

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Drazba Brian G.

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Reynolds Thomas C

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by White Christine Anna

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Urso David M

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4 filed by Kango Sujay

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1432d
  SEC Form 4: Ghalie Richard G covered exercise/tax liability with 8,196 shares, decreasing direct ownership by 22% to 28,927 units to satisfy withholding obligation

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1658d
  SEC Form 4 filed by Kango Sujay

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by White Christine Anna

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by Glover Nicholas

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by HOWSON TAMAR D

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by MEI Pharma, Inc.

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by DRISCOLL FREDERICK W

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by Cohen Cheryl

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by GHALIE RICHARD G

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by Baltic Charles V. III

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by Clemens Kevan

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4 filed by Drazba Brian G.

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4: GOLD DANIEL P PHD covered exercise/tax liability with 41,320 units of Common Stock, decreasing direct ownership by 9% to 417,312 units (withholding obligation)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1797d
  SEC Form 4: Urso David M covered exercise/tax liability with 24,825 units of Common Stock, decreasing direct ownership by 33% to 49,281 units (withholding tax)

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1838d
  SEC Form 4 filed by MEI Pharma, Inc.

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1860d
  SEC Form 4 filed by GHALIE RICHARD G

  4 - MEI Pharma, Inc. (0001262104) (Issuer)
• 1930d
  SEC Form 4: W Frederick Driscoll sold $100,625 worth of Common Stock (25,000 units at $4.03), decreasing ownership by 40% to 37,500 units

  4 - MEI Pharma, Inc. (0001262104) (Issuer)

Other MEIP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends